{"id":163933,"date":"2022-10-27T01:56:01","date_gmt":"2022-10-27T05:56:01","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/macrogenics-announces-date-of-third-quarter-2022-financial-results-conference-call\/"},"modified":"2024-08-18T11:45:38","modified_gmt":"2024-08-18T15:45:38","slug":"macrogenics-announces-date-of-third-quarter-2022-financial-results-conference-call","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/macrogenics-announces-date-of-third-quarter-2022-financial-results-conference-call.php","title":{"rendered":"MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call"},"content":{"rendered":"<p><![CDATA[ROCKVILLE, MD, Oct.  26, 2022  (GLOBE NEWSWIRE) -- \u00a0MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the third quarter of 2022 after the market closes on Thursday, November 3, 2022.\u00a0 MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, November 3, 2022, at 4:30 pm ET.]]><\/p>\n<p>Read this article:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/10\/26\/2542286\/0\/en\/MacroGenics-Announces-Date-of-Third-Quarter-2022-Financial-Results-Conference-Call.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call\">MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read this article: MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/macrogenics-announces-date-of-third-quarter-2022-financial-results-conference-call.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-163933","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163933"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=163933"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/163933\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=163933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=163933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=163933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}